A prospective randomized trial of rifampicin-minocycline coated and silver-platinum-carbon impregnated central venous catheters
There are no files associated with this record.
| Title | A prospective randomized trial of rifampicin-minocycline coated and silver-platinum-carbon impregnated central venous catheters |
|---|---|
| Author | Fraenkel, David; Rickard, Claire; Thomas, Peter; Faoagali, Joan; George, Narelle; Ware, Robert |
| Journal Name | Critical Care Medicine |
| Year Published | 2006 |
| Place of publication | USA |
| Publisher | Lippincott Wilkins & Williams |
| Abstract | OBJECTIVE: Central venous catheters are the predominant cause of nosocomial bacteremia; however, the effectiveness of different antimicrobial central venous catheters remains uncertain. We compared the infection rate of silver-platinum-carbon (SPC)-impregnated catheters with rifampicin-minocycline (RM)-coated catheters. DESIGN: A large, single-center, prospective randomized study. SETTING: Twenty-two-bed adult general intensive care unit in a large tertiary metropolitan hospital in Brisbane, Australia (2000-2001). PATIENTS: Consecutive series of all central venous catheterizations in intensive care unit patients. INTERVENTIONS: Randomization, concealment, and blinding were carefully performed. Catheter insertion and care were performed according to published guidelines. Blood cultures were taken at central venous catheter removal, and catheter-tip cultures were performed by both roll-plate and sonication techniques. Pulsed field gel electrophoresis was used to establish shared clonal origin for matched isolates. MEASUREMENTS AND MAIN RESULTS: Central venous catheter colonization and catheter-related bloodstream infection were determined with a blinded technique using the evaluation of the extensive microbiological and clinical data collected and a rigorous classification system. Six hundred forty-six central venous catheters (RM 319, SPC 327) were inserted, and 574 (89%) were microbiologically evaluable. Colonization rates were lower for the RM catheters than SPC catheters (25 of 280, 8.9%; 43 of 294, 14.6%; p=.039). A Kaplan-Meier analysis that included catheter time in situ did not quite achieve statistical significance (p=.055). Catheter-related bloodstream infection was infrequent for both catheter-types (RM 4, 1.4%; SPC 5, 1.7%). CONCLUSIONS: The SPC catheter is a clinically effective antimicrobial catheter; however, the RM catheter had a lower colonization rate. Both catheter types had low rates of catheter-related bloodstream infection. These results indicate that future studies will require similar rigorous methodology and thousands of central venous catheters to demonstrate differences in catheter-related bloodstream infection rates. |
| Peer Reviewed | Yes |
| Published | Yes |
| Publisher URI | http://www.ccmjournal.org/pt/re/ccm/home.htm;jsessionid=HcfB2x2dY5dhlGyrJzGL12r2bdSTs51cKZBcnJS6Lp6668MTnGY7!1071114923!181195629!8091!-1 |
| Copyright Statement | Copyright 2006 Lippincott, Williams & Wilkins. Self-archiving of the author-manuscript version is not yet supported by this publisher. Please use the hypertext link above to access the journal's website or contact the author for more information. |
| Volume | 34 |
| Issue Number | 3 |
| Page from | 668 |
| Page to | 675 |
| ISSN | 0090-3493 |
| Date Accessioned | 2007-05-10 |
| Date Available | 2009-01-12T06:23:17Z |
| Language | en_AU |
| Research Centre | Centre for Health Practice Innovation; Griffith Health Institute |
| Faculty | Griffith Health Faculty |
| Subject | Clinical Nursing: Secondary (Acute Care); Intensive Care |
| URI | http://hdl.handle.net/10072/15306 |
| Publication Type | Journal Articles (Refereed Article) |
| Publication Type Code | c1x |
Please use this identifier to cite this record: http://hdl.handle.net/10072/15306
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top